Agios Pharmaceuticals Prices Initial Public Offering Read more about Agios Pharmaceuticals Prices Initial Public Offering
Agios Pharmaceuticals Closes $33 Million Series A Funding Read more about Agios Pharmaceuticals Closes $33 Million Series A Funding
Agios Pharmaceuticals Expands Into 21,000 SqFt Facility Read more about Agios Pharmaceuticals Expands Into 21,000 SqFt Facility
Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team Read more about Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team
Agios Pharmaceuticals Appoints Charles Sawyers, M.D.,to Scientific Advisory Board Read more about Agios Pharmaceuticals Appoints Charles Sawyers, M.D.,to Scientific Advisory Board
Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR Read more about Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR
Agios Pharmaceuticals Appoints David Schenkein, M.D., as CEO and Duncan Higgons as COO Read more about Agios Pharmaceuticals Appoints David Schenkein, M.D., as CEO and Duncan Higgons as COO
Agios Pharmaceuticals' Focus of Drug Research - Cancer Metabolism - Selected for Stand Up To Cancer Grant Read more about Agios Pharmaceuticals' Focus of Drug Research - Cancer Metabolism - Selected for Stand Up To Cancer Grant
FierceBiotech Names Agios Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2009 Read more about FierceBiotech Names Agios Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2009
Agios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer Read more about Agios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer